Earnings

GT Biopharma Q2 EPS $(0.12) Misses $(0.08) Estimate

Aug 14, 2026 · 08:29 AM ET· updated 55m ago

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.08) by 50 percent. This is a 78.18 percent increase over losses of $(0.55) per share from the

Why It Matters

GT Biopharma lost more money per share than experts predicted, which is disappointing news. When a company loses more than expected, it can make people wonder if the business is on the right track.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

GTBP0.30

+0.00 (+1.21%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.